12 enrolling by invitation. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Enrolling by invitation 12 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors Desmopressin (DDAVP), Control - Craniopharyngiomas, Pituitary Macroadenoma | Phase 4 | Enrolling by invitation | Zhaoyun Zhang | 152 | 2026-06-02 | 2026-07-17 |
| Suzetrigine vs Norco-postoperative Mohs Pain Norco 5Mg-325Mg Tablet, Suzetrigine - Cutaneous Tumors, Mohs Micrographic Surgery | Phase 4 | Enrolling by invitation | Baylor Research Institute | 75 | 2025-11-03 | 2026-05-11 |
| Hematoporphyrin Photodynamic Therapy for Esophageal Cancer photodynamic therapy - Esophageal Cancer, Photodynamic Therapy | Phase 4 | Enrolling by invitation | Sun Yat-sen University | 198 | 2024-09-18 | 2026-05-22 |
| Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis Cryotherapy, 5Fluorouracil - Actinic Keratoses | Phase 4 | Enrolling by invitation | University of California, Davis | 73 | 2024-07-01 | 2026-07-06 |
| Cabergoline in the Management of Nonfunctioning Pituitary Adenoma Cabergoline 0.5 MG - Pituitary Adenoma, MRI | Phase 4 | Enrolling by invitation | National Taiwan University Hospital | 30 | 2024-05-20 | 2025-06-24 |
| Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia Low-dose ropivacaine, Medium-dose of ropivacaine, High-dose ropivacaine - Pediatric ALL | Phase 4 | Enrolling by invitation | Yilin Zhao | 180 | 2024-05-10 | 2024-12-02 |
| Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain Early TAP Block, Late TAP Block - Prostate Cancer | Phase 4 | Enrolling by invitation | Corewell Health East | 94 | 2024-02-19 | 2026-04-23 |
| Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts Enucleation, incisional biopsy, Application of 5-fluorouracil - Odontogenic Keratocyst | Phase 4 | Enrolling by invitation | University of Belgrade | 50 | 2023-06-10 | 2026-04-13 |
| Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria Atezolizumab, Bevacizumab - Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 4 | Enrolling by invitation | The Methodist Hospital Research Institute | 24 | 2023-01-30 | 2026-10-08 |
| LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe - Sarcoma, Soft Tissue Sarcoma | Phase 4 | Enrolling by invitation | Massachusetts General Hospital | 2868 | 2018-02-16 | 2026-10-09 |
| Quality Improvement and Practice Based Research in Neurology Using the EMR Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description) - Brain Tumors, Epilepsy | Phase 4 | Enrolling by invitation | Endeavor Health | 3300 | 2016-05-01 | 2025-08-24 |
| Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer Everolimus, Tacrolimus, Myfortic - Carcinoma, Hepatocellular | Phase 4 | Enrolling by invitation | Baylor Research Institute | 336 | 2014-03-01 | 2026-01-27 |
Carcinoma, Hepatocellular (2) · Bone Neoplasms (1) · Brain Concussion (1) · Brain Neoplasms (1) · Cognitive Dysfunction (1) · Craniopharyngioma (1) · Epilepsy (1) · Esophageal Neoplasms (1) · Hematoma (1) · Keratosis, Actinic (1) · Liver Neoplasms (1) · Migraine Disorders (1) · Multiple Sclerosis (1) · Odontogenic Cysts (1) · Parkinson Disease (1)
Neoplasms by Site (8) · Neoplasms by Histologic Type (5) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Adenocarcinoma (2) · Brain Diseases (2) · Carcinoma (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Immune System Diseases (2) · Liver Diseases (2) · Musculoskeletal Diseases (2) · Neoplasms, Glandular and Epithelial (2)
Aspirin (1) · Azathioprine (1) · Bevacizumab (1) · Cabergoline (1) · Cryotherapy (1) · Deamino Arginine Vasopressin (1) · Enoxaparin (1) · Everolimus (1) · Eye Enucleation (1) · Fluorouracil (1) · Magnetic Resonance Spectroscopy (1) · Mycophenolic Acid (1) · Photochemotherapy (1) · Ropivacaine (1) · Tacrolimus (1)
Baylor Research Institute (2) · Corewell Health East (1) · Endeavor Health (1) · Massachusetts General Hospital (1) · National Taiwan University Hospital (1) · Sun Yat-sen University (1) · The Methodist Hospital Research Institute (1) · University of Belgrade (1) · University of California, Davis (1) · Yilin Zhao (1) · Zhaoyun Zhang (1)
United States (7) · China (3) · Canada (1) · Serbia (1) · Taiwan (1)
Daniel Eisen, MD (1) · Goran Klintmalm, MD, PhD (1) · Miroslav Andric (1) · S. Mohammad Jafri, MD (1) · Santiago A Lozano-Calderon, MD, PhD (1) · Stan Tolkachjov, MD (1) · Yilin Zhao, M.D, Ph.D (1)
PMID 14557435, PMID 16235676, PMID 23195688, PMID 23959584, PMID 2496905, PMID 25587648, PMID 25677941, PMID 30028528, PMID 32503055, PMID 32712149, PMID 32792133, PMID 32800304, PMID 33159114, PMID 33527610, PMID 35090129, PMID 35191944, PMID 35671519, PMID 37533236, PMID 38995891, PMID 39539913, PMID 39830821, PMID 40581268, PMID 41221987